The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
May 15th 2024
New analyses show adults aged ≥65 years old are at about 30% increased risk of hypertension when diagnosed with diabetes mellitus.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
FDA Approves PASCAL Precision System for TEER in Degenerative Mitral Regurgitation
September 16th 2022Announced on September 15 by Edwards Lifesciences Corporation, the PASCAL Precision transcatheter valve repair system has received approval for transcatheter edge-to-edge repair in patients with degenerative mitral regurgitation.
Don't Miss a Beat: ESC Congress 22 Recap
September 16th 2022In this episode of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, provide a recap of the European Society of Cardiology Congress 2022. This recap begins with a discussion on the results of the phase 3 DELIVER trial, in which Vaduganathan served as an investigator, the ADVOR trial, and REVIVED.
DASH Diet Could Prevent 25,000+ Cardiovascular Events in those with Stage 1 Hypertension
September 7th 2022A new study from the AHA's Hypertension Scientific Sessions provides an overview of the potential population-level benefit of behavior modification, including adherence to a DASH diet, on CVD events and mortality among patients with stage 1 hypertension.
FDA Expands WATCHMAN FLX Approval to Include DAPT Option
September 6th 2022Announced by Boston Scientific on September 6, the label for the WATCHMAN FLX LAAC device now includes a 45-day DAPT option as an alternative to the 45-day postprocedural OAC plus aspirin regimen for patients with nonvalvular atrial fibrillation.
Cardiology Case Report: Right Leg Pain, Swelling
September 6th 2022Our latest cardiology case report from Brady Pregerson, MD, features a man in his mid-50s presenting to the hospital with leg swelling that started 4 days ago but denies chest pain, SOB or other complaints. Check out the ECG and determine the correct diagnosis.
COVID-19-Related Cardiovascular Complications in Pregnancy, with Gregory Weiss, MD
September 5th 2022In his most recent column, Dr. Gregory Weiss provides an overview of a recent American College of Cardiology report detailing apparent increases in cardiovascular risk observed among pregnant women infected with COVID-19.
Finerenone Reduces All-Cause Mortality, Sudden Cardiac Death in Type 2 Diabetes
August 29th 2022An analysis of the FIDELITY program from ESC Congress 2022 details an 11% reduction in risk of all-cause mortality and a 25% reduction in risk of sudden cardiac death among patients with type 2 diabetes and chronic kidney disease.